Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Leon Gordis, Kimberly D. Gregory, Russell Harris, George Isham, Michael L. LeFevre, Carol Loveland-Cherry, Lucy N. Marion, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Albert L. Siu, Steven M. Teutsch, Barbara P. Yawn

Research output: Contribution to journalReview articlepeer-review

97 Scopus citations

Abstract

Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).

Original languageEnglish (US)
Pages (from-to)759-765
Number of pages7
JournalAnnals of internal medicine
Volume148
Issue number10
DOIs
StatePublished - May 20 2008
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement'. Together they form a unique fingerprint.

Cite this